Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu
  • quotes

  • charts

  • technicals

  • company

Briacell Therapeutics Corp (BCTXF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0820 +58.54%
on 05/24/18
0.1350 -3.70%
on 06/19/18
+0.0485 (+59.51%)
since 05/22/18
3-Month
0.0680 +91.18%
on 05/18/18
0.1350 -3.70%
on 06/19/18
+0.0317 (+32.25%)
since 03/21/18
52-Week
0.0680 +91.18%
on 05/18/18
0.1462 -11.08%
on 08/25/17
-0.0079 (-5.73%)
since 06/22/17

Most Recent Stories

More News
BriaCell to Hold Conference Call on Key Clinical Findings; Activities

BriaCell Therapeutics Corp. ("BriaCell") (TSX-V:BCT) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, is pleased to provide a Corporate...

BCTXF : 0.1300 (+1.56%)
BCT.VN : 0.170 (+3.03%)
BriaCell Therapeutics Corp. to Present at The MicroCap Conference on June 21st in Toronto at the Sheraton Centre Hotel

TORONTO, ON / ACCESSWIRE / June 13, 2018 / BriaCell Therapeutics Corp. ("BriaCell") (TSX-V: BCT) (OTCQB: BCTXF), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy...

BCTXF : 0.1300 (+1.56%)
BCT.VN : 0.170 (+3.03%)
BriaCell Publishes Clinical Findings in 2018 American Society of Clinical Oncology (ASCO) Meeting

BriaCell Therapeutics Corp. ("BriaCell") (TSX-V:BCT) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, announced today that it will publish...

BCTXF : 0.1300 (+1.56%)
BCT.VN : 0.170 (+3.03%)
BriaCell Activates A Clinical Site in Florida for Phase IIa Study of its Lead Candidate in Advanced Breast Cancer

BriaCell Therapeutics Corp. ("BriaCell") (TSX-V:BCT) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, is pleased to announce that Sylvester...

BCTXF : 0.1300 (+1.56%)
BCT.VN : 0.170 (+3.03%)
BriaCell Provides Highlights of Scientific and Clinical Findings at AACR

BriaCell Therapeutics Corp. ("BriaCell") (TSX-V:BCT) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, is pleased to announce that it...

BCTXF : 0.1300 (+1.56%)
BCT.VN : 0.170 (+3.03%)
Dr. Williams, BriaCell Therapeutics Corp.'s President & CEO, is Featured in an Exclusive New Audio Interview with SmallCapVoice.com

SmallCapVoice.com, Inc. and BriaCell Therapeutics Corp. ("BriaCell") (TSXV:BCT.V) (OTC:BCTXF), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, announced...

BCTXF : 0.1300 (+1.56%)
BriaCell to Present Encouraging Clinical Data at AACR 2018

BriaCell Therapeutics Corp. ("BriaCell") (TSX-V:BCT) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, announced today that it has been...

BCTXF : 0.1300 (+1.56%)
BCT.VN : 0.170 (+3.03%)
BriaCell's Lead Product Candidate Mechanism of Action Described in a Major Immunology Journal

BriaCell Therapeutics Corp. ("BriaCell") (TSX-V:BCT) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, is pleased to announce the acceptance...

BCTXF : 0.1300 (+1.56%)
BCT.VN : 0.170 (+3.03%)
BriaCell Completes Previously Announced Oversubscribed Non-Brokered Private Placement and Concurrent Investment With Leading U.S. Biotech Funds

BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, is pleased to...

BCTXF : 0.1300 (+1.56%)
BCT.VN : 0.170 (+3.03%)
BriaCell Appoints Top Social Media Marketing Analyst

BriaCell Therapeutics Corp. ("BriaCell") (TSX-V:BCT) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, announced that it has engaged...

BCTXF : 0.1300 (+1.56%)
BCT.VN : 0.170 (+3.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators mostly agree with the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade BCTXF with:

Key Turning Points

2nd Resistance Point 0.1300
1st Resistance Point 0.1300
Last Price 0.1300
1st Support Level 0.1300
2nd Support Level 0.1300

See More

52-Week High 0.1462
Last Price 0.1300
Fibonacci 61.8% 0.1163
Fibonacci 50% 0.1071
Fibonacci 38.2% 0.0979
52-Week Low 0.0680

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar